deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03032250

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer Caregivers

Sponsor: National Cancer Institute (NCI)

Conditions Caregiver Malignant Head and Neck Neoplasm Paranasal Sinus Squamous Cell Carcinoma Recurrent Head and Neck Squamous Cell Carcinoma Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Lip and Oral Cavity Squamous Cell Carcinoma Recurrent Oropharyngeal SCC Recurrent Paranasal Sinus Squamous Cell Carcinoma Salivary Gland Squamous Cell Carcinoma Stage I Hypopharyngeal Squamous Cell Carcinoma Stage I Laryngeal Squamous Cell Carcinoma Stage I Lip and Oral Cavity Squamous Cell Carcinoma Stage I Oropharyngeal Squamous Cell Carcinoma Stage II Hypopharyngeal Squamous Cell Carcinoma Stage II Laryngeal Squamous Cell Carcinoma Stage II Lip and Oral Cavity Squamous Cell Carcinoma Stage II Oropharyngeal Squamous Cell Carcinoma Stage III Hypopharyngeal Squamous Cell Carcinoma Stage III Laryngeal Squamous Cell Carcinoma Stage III Lip and Oral Cavity Squamous Cell Carcinoma Stage III Oropharyngeal Squamous Cell Carcinoma Stage IV Hypopharyngeal Squamous Cell Carcinoma Stage IV Laryngeal Squamous Cell Carcinoma Stage IV Lip and Oral Cavity Squamous Cell Carcinoma Stage IV Oropharyngeal Squamous Cell Carcinoma Stage IVA Hypopharyngeal Squamous Cell Carcinoma Stage IVA Laryngeal Squamous Cell Carcinoma Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma Stage IVA Oropharyngeal Squamous Cell Carcinoma Stage IVB Hypopharyngeal Squamous Cell Carcinoma Stage IVB Laryngeal Squamous Cell Carcinoma Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma Stage IVB Oropharyngeal Squamous Cell Carcinoma Stage IVC Hypopharyngeal Squamous Cell Carcinoma Stage IVC Laryngeal Squamous Cell Carcinoma Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma Stage IVC Oropharyngeal Squamous Cell Carcinoma
Updated 20 times since 2017 Last updated: Dec 14, 2022 Started: May 15, 2017 Primary completion: Apr 10, 2020 Completion: Apr 10, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Caregiver and Malignant Head and Neck Neoplasm and is currently completed. National Cancer Institute (NCI) leads this study, which shows 20 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Jun 2017 · 31 days · monthly snapshot~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Jun 2019 · 10 months · monthly snapshot~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshot~Sep 2019 – ~Nov 2019 · 2 months · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Apr 2020 · 3 months · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Jan 2022 · 4 months · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Feb 2023 · 12 months · monthly snapshot~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

20 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Feb 2023 — Jul 2024 [monthly]

    Completed NA

  4. Feb 2022 — Feb 2023 [monthly]

    Completed NA

  5. Jan 2022 — Feb 2022 [monthly]

    Completed NA

Show 15 earlier versions
  1. Sep 2021 — Jan 2022 [monthly]

    Completed NA

  2. Apr 2021 — Sep 2021 [monthly]

    Completed NA

  3. Jan 2021 — Apr 2021 [monthly]

    Completed NA

  4. May 2020 — Jan 2021 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

  5. Apr 2020 — May 2020 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  6. Jan 2020 — Apr 2020 [monthly]

    Recruiting NA

  7. Dec 2019 — Jan 2020 [monthly]

    Recruiting NA

  8. Nov 2019 — Dec 2019 [monthly]

    Recruiting NA

  9. Sep 2019 — Nov 2019 [monthly]

    Recruiting NA

  10. Jun 2019 — Sep 2019 [monthly]

    Recruiting NA

  11. Aug 2018 — Jun 2019 [monthly]

    Recruiting NA

  12. Jun 2018 — Aug 2018 [monthly]

    Recruiting NA

  13. Jun 2017 — Jun 2018 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  14. May 2017 — Jun 2017 [monthly]

    Not Yet Recruiting NA

  15. Feb 2017 — May 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Wake Forest University Health Sciences
Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations